Clinical Trial

CM336 for Active Sjogren's Syndrome Study

Name: CM336 for Active Sjogren's Syndrome Study — clinical trial record (NCT07642843)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and efficacy of CM336 in adult participants with active primary Sjogren's Syndrome.

Protocol Amendment History 1 change

critical Primary endpoint(s) modified 2026-06-13

Trial Details

NCT Number	NCT07642843
Lead Sponsor	Keymed Biosciences Co.Ltd
Conditions	Primary Sjögren's Syndrome (pSS)
Enrollment	30 participants
Start Date	2026-06
Primary Completion	2028-04 (estimated)
Study Completion	2029-02 (estimated)
Updated on ClinicalTrials.gov	2026-06-12